[{"id":"7204e2a6-dc66-4d87-87cb-75b6b508cd0a","acronym":"KisMET-01","url":"https://clinicaltrials.gov/study/NCT05652868","created_at":"2022-12-15T14:58:22.414Z","updated_at":"2025-02-25T15:20:09.822Z","phase":"Phase 1","brief_title":"Clinical Study of Antibody-Drug Conjugate MYTX-011 in Subjects With Non-Small Cell Lung Cancer","source_id_and_acronym":"NCT05652868 - KisMET-01","lead_sponsor":"Mythic Therapeutics","biomarkers":" MET","pipe":" | ","alterations":" MET amplification • MET exon 14 mutation","tags":["MET"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MET amplification • MET exon 14 mutation"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MYTX-011"],"overall_status":"Recruiting","enrollment":" Enrollment 250","initiation":"Initiation: 03/23/2023","start_date":" 03/23/2023","primary_txt":" Primary completion: 12/01/2025","primary_completion_date":" 12/01/2025","study_txt":" Completion: 12/01/2027","study_completion_date":" 12/01/2027","last_update_posted":"2025-02-12"}]